Cannabis Science believes that continued efforts to inform the public about the importance of cannabis based medicines. They are succeeded by doing this through an interview with Dr. Robert Melamede, Cannabis Science President and CEO on StockGoodies at 8:30 AM Eastern. He explained, "Cannabis Science Inc, as its name implies, is using the latest scientific techniques to develop standardized cannabis extracts that can be used in a variety of ways to help patients." He emphasized that Cannabis Science is a "patient oriented company" that works closely with the medical marijuana movement, observing what people need and what works best for them.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
